Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors
Akash J. Patel, Ying-Wooi Wan, Rami Al‐Ouran, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 43, pp. 21715-21726
Open Access | Times Cited: 155

Showing 26-50 of 155 citing articles:

Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free Survival
Valeria Barresi, Michele Simbolo, Adele Fioravanzo, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 903-903
Open Access | Times Cited: 28
Intratumor and informatic heterogeneity influence meningioma molecular classification
Harish N. Vasudevan, Abrar Choudhury, Stephanie Hilz, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 3, pp. 579-583
Open Access | Times Cited: 21
Identification and Management of Aggressive Meningiomas
Bhuvic Patel, Rupen Desai, Sangami Pugazenthi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 20
Theranostics in Neurooncology: Heading Toward New Horizons
Nelleke Tolboom, Antoine Verger, Nathalie L. Albert, et al.
Journal of Nuclear Medicine (2023) Vol. 65, Iss. 2, pp. 167-173
Open Access | Times Cited: 11
Atypical meningioma: Histopathological, genetic, and epigenetic features to predict recurrence risk.
Elena Marastoni, Valeria Barresi
PubMed (2024) Vol. 39, Iss. 3, pp. 293-302
Closed Access | Times Cited: 4
Emerging Role of the DREAM Complex in Cancer and Therapeutic Opportunities
You-Jin Hwang, Moon Jong Kim
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 322-322
Open Access
The Impact of MRI-Defined Extent of Resection Across Meningioma DNA Methylation Groups: Re-Evaluating Surgery in the Era of Meningioma Molecular Classification
Ramin A. Morshed, Minh Nguyen, Abrar Choudhury, et al.
Neurosurgery (2025)
Closed Access
Malignant Meningiomas: From Diagnostics to Treatment
Hojka Rowbottom, Tomaž Šmigoc, Janez Ravnik
Diagnostics (2025) Vol. 15, Iss. 5, pp. 538-538
Open Access
Refining prognostic stratification of atypical meningiomas: significance of chromosome 1p deletion and brain invasion
Giovanni Zanconato, Gonzalo Hernandez Gamero, Andrea Mafficini, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
The role of meningioma epigenetics in routine clinical practice
Lydia Karamani, Wolf Müller, Max Braune, et al.
Research Square (Research Square) (2025)
Closed Access
Diagnostic and prognostic potential of cell-free RNAs in cerebrospinal fluid and plasma for brain tumors
Jinyong Huang, Jinxia Zhou, Jun Wang, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Integrated Clinical Genetic Analysis of Meningiomas Causing Bony Hyperostosis Shows More Severe Clinical Course and Overexpression of Secreted Pro-osteogenic Factors
Malcolm F. McDonald, Abdul Wali Khan, Andrew C. Chang, et al.
Neurosurgery (2025)
Closed Access
Meningiomas from a developmental perspective: exploring the crossroads between meningeal embryology and tumorigenesis
Julien Boetto, Matthieu Peyre, Michel Kalamarides
Acta Neurochirurgica (2020) Vol. 163, Iss. 1, pp. 57-66
Closed Access | Times Cited: 32
The management of incidental meningioma: An unresolved clinical conundrum
Abdurrahman I. Islim, Christopher P. Millward, Samantha J. Mills, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. Supplement_1, pp. i26-i34
Open Access | Times Cited: 10
Recent advances in the molecular prognostication of meningiomas
Elaina J. Wang, Alexander F. Haddad, Jacob S. Young, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 9
Pediatric meningiomas: A literature review and diagnostic update
Arnault Tauziède‐Espariat, Stefan M. Pfister, Christian Mawrin, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. Supplement_1, pp. i105-i111
Open Access | Times Cited: 9
Aggressive human MenG C meningiomas have a molecular counterpart in canines
Akdes Serin Harmancı, Beth Boudreau, Sean K. Lau, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Closed Access | Times Cited: 3
RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups
Nathan K. Leclair, Abrar Choudury, William Chen, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 12, pp. 2222-2236
Open Access | Times Cited: 3
Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma
Huiyuan Zhang, Lin Qi, Yuchen Du, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1478-1478
Open Access | Times Cited: 27
A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After Resection
William Chen, Harish N. Vasudevan, Abrar Choudhury, et al.
Neurosurgery (2020) Vol. 88, Iss. 1, pp. 202-210
Open Access | Times Cited: 25
Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas
Alexander Pemov, Ramita Dewan, Nancy F. Hansen, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Chemotherapy and targeted therapies for meningiomas: what is the evidence?
Thomas Graillon, Émeline Tabouret, Olivier Chinot
Current Opinion in Neurology (2021) Vol. 34, Iss. 6, pp. 857-867
Closed Access | Times Cited: 23
The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications
Stephanie M. Robert, Shaurey Vetsa, Arushii Nadar, et al.
Journal of Neuro-Oncology (2021) Vol. 156, Iss. 2, pp. 205-214
Open Access | Times Cited: 23
CDK 4/6 inhibitors for the treatment of meningioma
Jacob S. Young, Reilly L. Kidwell, Allison Zheng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Fractionated radiotherapy for surgically resected intracranial meningiomas: A multicentre retrospective cohort study
Justin Z. Wang, Farshad Nassiri, Alexander Landry, et al.
Radiotherapy and Oncology (2023) Vol. 188, pp. 109861-109861
Closed Access | Times Cited: 9

Scroll to top